Submitted by Anonymous (not verified) on 20 November 2023 - 11:53
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Multiple Myeloma, Date of authorisation: 20/05/2016, Revision: 21, Status: Authorised
Source:
